About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Tuesday, October 16th, 2012

The QualityStocks
Daily Stock List

graphic
graphic

VisionChina Media, Inc. (VISN)

Street Insider and Hit and Run Candle Sticks reported earlier on VisionChina Media, Inc. (VISN), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Founded in 2005, VisionChina Media, Inc. is one of China's largest out-of-home digital television advertising networks on mass transportation systems. The Company operates a network on mass transportation systems, including buses and subways. VisionChina Media can deliver real-time, location-specific broadcasting. This includes news, stock quotes, weather and traffic reports, and other entertainment programming. In addition, the Company sells digital television displays or passenger information and direction systems to their local operating partners. The Company has their headquarters in Shenzhen, the People's Republic of China.

As of June 30, 2012, VisionChina Media's advertising network included 136,075 digital television displays on mass transportation systems in 20 of China's economically prosperous cities, including Beijing, Shanghai, Guangzhou and Shenzhen, as secured by exclusive agency agreements or joint venture contract. VisionChina Media sells their advertising time via a direct sales force as well as third party advertising agencies.

VisionChina Media operates mobile digital television displays on bus networks in Beijing, Guangzhou, Shenzhen, Suzhou, Wuxi, Chengdu, Ningbo, Nanjing, Wuhan, Dalian, Shenyang, Zhengzhou, Changchun, Changzhou, Changsha, Taiyuan and Xiamen. Additionally, the Company operates on the subways of Beijing, Shanghai, Guangzhou, Shenzhen, Nanjing, Tianjin, Chongqing and Hong Kong.

In each of the cities in which the Company operates, they have contractual or direct investment arrangements with the local television station and the station's mobile broadcast subsidiary. These long-term relationships allow VisionChina Media to provide domestic and multinational corporations a unique media opportunity to reach massive mobile Chinese audiences.

In late August, VisionChina Media announced the appointment of Mr. Stanley Yan Wang as the Company's Chief Financial Officer. Mr. Wang joined VisionChina Media as Financial Controller in March of 2009. He later served as Senior Vice President of Finance, taking charge of the Company's daily financial operations. Before joining VisionChina Media, Mr. Wang was an audit manager at KPMG Guangzhou. Mr. Wang holds a Bachelor's degree from Guangdong University of Foreign Studies in Guangdong, China.

VisionChina Media, Inc. (VISN), closed Tuesday’s session at $0.22, up 4.27%, on 54,850 volume with 71 trades. The average volume for the last 60 days is 393,690 and the stock's 52-week low/high is $0.15/$1.90.

Energizer Resources, Inc. (ENZR)

SmallCapVoice and Stockhouse reported earlier on Energizer Resources, Inc. (ENZR), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.

Headquartered in Toronto, Ontario, Energizer Resources, Inc. is a mineral exploration and development company. The Company is developing their Green Giant Vanadium and Graphite Project in conjunction with their Madagascar-ERG Joint Venture (Mauritius) Ltd. property. The Green Giant vanadium deposit is one of the largest known vanadium deposits in the world. Energizer Resources lists on the OTCQB.

Energizer Resources is the only enterprise actively targeting to produce battery-grade vanadium as a primary product. Currently, the Company is targeting production by the end of 2014. Their deposit is distinct from other known Vanadium deposits because it is sediment-hosted and not magnetite-hosted like the majority of other known Vanadium deposits.  Due to this, Energizer expects to produce clean liquor requiring less processing to produce the high purity (99.5 percent), battery-grade vanadium.

The Company's Malagasy JV Graphite Project is in Madagascar adjacent to their Green Giant Project. Graphite is an excellent conductor of heat and electricity, and has the highest natural strength and stiffness of any material. The Company also has their Malagasy JV Vanadium Project.

In September, Energizer Resources announced that they received additional assays from their National Instrument (NI) 43-101 graphite resource drill program on the Molo deposit. The Molo deposit is situated in the Green Giant Graphite project, and is part of the Joint Venture (JV) property with Malagasy Minerals Ltd. in Madagascar. Energizer Resources has a 75 percent ownership interest and is the operator of the project. The results continue to outline the targeted deposit size and boundaries and the grade of the Molo deposit. The Company is focusing their resource delineation program on the Molo deposit.

Energizer Resources has received assay results from an additional 9 diamond drill holes and 1 trench. The Company has now received a combined 24 (of 47) drill holes, and 10 (of 19) trenches completed over the Molo deposit. This dataset continues to confirm that the Molo deposit has a very large footprint.

Energizer Resources, Inc. (ENZR), closed Tuesday’s session at $0.368, up 2.22%, on 80,600 volume with 22 trades. The average volume for the last 60 days is 76,247 and the stock's 52-week low/high is $0.15/$0.484.

Zonte Metals, Inc. (ZON.V)

We are highlighting Zonte Metals, Inc. (ZON.V) today, here at the QualityStocks Daily Newsletter.

Headquartered in Bedford, Nova Scotia, Zonte Metals, Inc. is a newly formed junior exploration company focusing on gold. The Company is looking for other high quality projects for acquisition in politically stable jurisdictions worldwide. Their business model is to find projects with large scale potential and the Company is actively reviewing and completing field due diligence on projects in the United States, Canada and South America. Zonte Metals shares trade on the TSX Venture Exchange.

Zonte has completed one acquisition so far; this is in Newfoundland and Labrador. The project in Newfoundland and Labrador is called the Wings Point Gold Project. This Project is potentially a Carlin style gold system. Zonte Metals is continuing to look for their second significant project. Zonte's model is to look for projects that have the potential of 2-plus Million ounces of gold, whether grass roots to partially drilled.

The Wings Point Gold Property is located on the island portion of Newfoundland and Labrador. It is approximately 30 kilometers north of Gander. The Project consists of 910 contiguous mineral claims covering 22,750 hectares. Access throughout the property is excellent with paved and logging roads throughout the Wings Point Gold Property.

The Company acquired this property based on disseminated bulk tonnage mineralization exposed at the bottom of an operating gravel pit. This belt has undergone exploration for the last 20 years, mostly concentrating on narrow high-grade gold structures.  Zonte Metals will be exploring their holdings focusing on the sediment hosted bulk tonnage potential.

This past August, Zonte Metals provided an update on the Wings Point Project. Phase II at the Wings Point Gold Project began; it consists of approximately 50 line kilometers of induced polarization (IP) and magnetic surveys. The program will be carried out over eight different grids throughout the project, targeting areas of interest that have been generated from Zonte Metal's exploration work and compiled historic datasets.

The most advanced target on the Wings Point project is the Pit Target. Two undrilled geophysical targets coincident with bedrock gold mineralization partially exposed in an operating gravel pit characterize the Pit Target. The present geophysical program includes additional surveying on the Pit Target to reduce the present line spacing of 200 meters down to 100 meters.

Zonte Metals, Inc. (ZON.V), closed Tuesday’s session at $0.105 up 10.53%, on 50,500 volume. The stock's 52-week low/high is $0.05/$0.40.

Perpetual Energy, Inc. (PMGYF)

We are highlighting Perpetual Energy, Inc. (PMGYF) today, here at the QualityStocks Daily Newsletter.

Listed on the OTCQX International, Perpetual Energy, Inc. is an independent energy company. The Company is producing primarily natural gas with growing volumes of oil and liquids from properties in Alberta. Perpetual Energy launched on July 1, 2010 via the corporate conversion of Paramount Energy Trust, a royalty trust with a seven-year history as a premium-yielding investment in the royalty trust sector. Perpetual Energy is based in Calgary, Alberta.

The Company is successfully transitioning from being a 100 percent conventional shallow gas trust to a diversified, resource-style, growth-oriented company. Their exposure is to resource-style plays in the west central Alberta deep basin. These include leading plays in the Canadian upstream oil and gas industry.

Perpetual Energy's strategy for Base Assets includes building a diversified portfolio of resource-style, high return assets for short and long-term growth. The Company's strategy also includes exploration in both oil and gas resource plays and new ventures with high impact potential. They are also working to harness opportunities within their assets where emerging and advanced technologies will create, the Company believes, value well into the future 

Perpetual Energy has properties in the Eastern and Western Districts of Alberta. The Eastern District consists of assets in northeast and east central Alberta. Production in this multi-zoned potential area consists of conventional and tight unconventional shallow gas reservoirs as well as conventional heavy oil. The northern part of this district largely overlaps the Athabasca Oil Sands area.

The Company has also amassed a material inventory of oil sands leases for future development that will require a variety of subsurface recovery technologies. A significant majority of their shallow gas properties feature well established, high working interest production. Perpetual operates most of them.

Perpetual's strategic focus on growth in west central Alberta began in 2008 with grass roots exploration, which resulted in the purchase of a significant Crown acreage position for Montney gas in the Elmworth area south of Grande Prairie. The objective was to complement their existing shallow gas prospect inventory with higher impact, deep basin style, liquids-rich resource play opportunities. In 2009, Perpetual completed the acquisition of Profound Energy, Inc. with focused assets in the Pembina/Carrot Creek area. In 2010, they acquired more assets in the Edson area to establish the West Central district further.

Perpetual Energy, Inc. (PMGYF), closed Tuesday’s session at $1.43, up 4.95%, on 39,669 volume with 14 trades. The average volume for the last 60 days is 24,196 and the stock's 52-week low/high is $0.571/$2.30.

Kennady Diamonds, Inc. (KDI.V)

We are highlighting Kennady Diamonds, Inc. (KDI.V) today, here at the QualityStocks Daily Newsletter.

Listed on the TSX Venture Exchange, Kennady Diamonds, Inc. is a leading Canadian diamond exploration company with headquarters in Toronto, Ontario. Their exploration focus is on 13 leases and claims (100 percent controlled), located immediately adjacent to the De Beers/Mountain Province Diamonds joint venture property in the Northwest Territories (NT). Kennady Diamonds controls 100 percent of the Kennady North project.

The Kennady North Project is 280 kilometers east-northeast of Yellowknife, NT in the District of Mackenzie. The property consists of five mineral leases and eight mineral claims totaling 30,532 acres, or 12,356 hectares. The project covers an area approximately 20 kilometers long and 15 kilometers wide.

Exploration at Kennady North began in the late 1990's. It resulted in the discovery of the diamond-bearing Kelvin, Faraday and Hobbes kimberlites. Exploration samples from Kelvin and Faraday returned a relatively large number of macro diamonds with the two largest being a 0.4 carat diamond from Faraday and a 0.09 carat diamond from Kelvin.

Exploration at Kennady North began again in 2011 with a 50-meter line-spacing airborne gravity gradiometry (AGG) survey over the entire 123.6 square kilometer project area. The survey identified 106 geophysical targets. Mountain Province recently completed a 560-line-kilometer total magnetic field (MAG) ground survey over all 106 geophysical targets identified by the AGG survey. The 39 high priority targets identified through the AGG and MAG surveys will undergo testing as part of the 2012 summer drill program and planned 2013 winter drill program (approximately 20 drill targets).

In August, Kennady Diamonds announced that a second drill hole at Kelvin Lake intersected kimberlite over approximately 32 meters from a down-hole depth of approximately 104 meters to approximately 136 meters. This inclined hole was drilled from the northwest shore of Kelvin Lake at an angle of approximately minus 60 degrees to the east-southeast. Kimberlite recovered during the Kennady North summer drill program went to the Saskatchewan Research Council analytical laboratory for microdiamond testing by caustic fusion.

Kennady Diamonds, Inc. (KDI.V), closed Tuesday’s session at $1.34, up 5.51%, on 17,528 volume. The stock's 52-week low/high is $0.98/$1.49.

Mabwe Minerals, Inc. (MBMI)

Today we are reporting on Mabwe Minerals, Inc. (MBMI), here at the QualityStocks Daily Newsletter.

Incorporated in Wyoming, Mabwe Minerals, Inc. is a natural resources and hard asset company. They engage in the mining and commercial sales of industrial minerals and metals. The Company's first focus is on barite. Barite is an industrial mineral used as a weighting agent by oil and gas drilling companies. Raptor Resources Holdings owns 90 million shares of Mabwe Minerals or approximately 80 percent of their issued and outstanding shares of common stock. Raptor Resources is the parent/holding Company with three independently operating subsidiaries: TAG Minerals, Inc., Mabwe Minerals and Lantis Laser, Inc. Mabwe Minerals lists on the OTCQB.

Mabwe Minerals was established to optimize the abundant mineral/metal resources of Raptor Resources' world class, hydrothermal mountain range, home to the Dodge Mine located in Shamva, Zimbabwe.  Because of its unique hydrothermal structure, high grade minerals are abundant including barite, limestone/marble and talc.  Of interest are extensive occurrences of undeveloped gossans deposits indicating the presence of a massive sulphide deposit that may contain gold, nickel, copper and/or lead.  The presence of these metabasalts could be indicative of gold in the host rock.
 
In August, Raptor Resources Holdings announced that their majority-owned subsidiary, Mabwe Minerals acquired 49 percent of Mabwe Minerals Zimbabwe (Private) Ltd. in exchange for 25,000 shares of Raptor Resources Series B convertible preferred stock that allow each holder of such shares to convert into both Raptor Resources and Mabwe Minerals shares of common stock following a one year holding period. This organizational structure meets the Zimbabwe Indigenous Law requiring 51 percent native ownership.

Raptor Resources' wholly owned subsidiary, TAG Minerals, owns 49 percent of TAG Minerals Zimbabwe (Private) Ltd. TAG Minerals is the parent company's mineral resource acquisition, exploration and development subsidiary. TAG acquired the Dodge Mine and recently completed an extensive gravity mapping program confirming the presence of a large hydrothermal deposit of barite stretching a minimum of 1.5 kilometers across the original Dodge Mine property boundary. TAG Minerals recently transferred all of their mineral rights relating to Dodge Mine Blocks 1 to 6 to Mabwe Minerals, to begin the mining and commercial sales of barite.

Mabwe Minerals, Inc. (MBMI), closed Tuesday’s session at $0.12, up 50.00%, on 40,309 volume with 9 trades. The average volume for the last 60 days is 10,200 and the stock's 52-week low/high is $0.0056/$0.25.

Visualant, Inc. (VSUL)

Greenbackers reported yesterday on Visualant, Inc. (VSUL), Pennybuster did last week, Wall Street Resources did earlier, and we highlight the Company, here at the QualityStocks Daily Newsletter.

Visualant, Inc. develops industry-leading color-based identification and diagnostic solutions, and security and authentication systems. These rely on the Company's unique proprietary Spectral Pattern Matching (SPM) technology. Visualant develops low-cost, high speed, light-based security and quality control solutions for use in homeland security, anti-counterfeiting, forgery/fraud prevention, brand protection and process control applications. Visualant has their corporate headquarters in Seattle, Washington.

Visualant's patented and patent-pending technology - Spectral Pattern Matching (SPM) - utilizes controlled illumination with specific bands of light, to establish a unique spectral signature for both individual and classes of items. When matched against existing databases, these spectral signatures allow precise identification and authentication of any item or substance. This technology directs structured light onto a physical substance to capture a unique ChromaID™ profile. When matched against existing databases, the Visualant Spectral Signature™ can identify, detect, or diagnosis markers invisible to the human eye. SPM scanners can undergo integration into an array of mobile or fixed-mount form factors. This makes it possible to conduct analyses in the field effectively, that could only previously be performed by large and expensive lab-based tests.

Visualant entered into a one-year Joint Development Agreement on May 31, 2012 with Sumitomo Precision Products Co., Ltd. (SPP), which focuses on the commercialization of the SPM technology and a License Agreement providing SPP with an exclusive license of the SPM technology in identified Asian territories.

SPM technology can be combined in the same package as a bar code or biometric scanner. Through their wholly owned subsidiary, TransTech Systems, Inc. (operating from Aurora, Oregon), Visualant provides security and authentication solutions to security and law enforcement markets throughout the U.S. TransTech Systems is a leading distributor in card issuance systems and components. Their expertise is in card printers, card encoders, and peripheral equipment.

Last week, Visualant unveiled (at the Japan Inspection Instruments Manufacturers' Show (JIMA) on October 10-12, 2012, held in Tokyo) prototypes of new hardware manufactured by their investor and partner, SPP. New device prototypes from SPP demonstrate the power of Visualant's ChromaID™ technology. This technology reads, records, and analyzes invisible chromatic identifiers in gases, liquids, solids and surfaces. The expectation is that these prototypes will generate a new wave of consumer and industrial applications bringing the benefits of Visualant Spectral Pattern Matching™ (SPM) techniques found in expensive science labs to people in the field.

Visualant, and their development partner SPP introduced ChromaID™ technology that can be embedded into future industrial devices and consumer electronics, including smartphones and laptops. The ChromaID™ system was invented by University of Washington Professors Thomas Furness and Brian Schowengerdt. An advanced method of Spectral Pattern Matching (SPM) techniques, it is more accurate and precise than previous SPM techniques. It can undergo deployment into the field at large economies of scale.

Visualant, Inc. (VSUL), closed Tuesday’s session at $0.13, down 7.14%, on 10,374 volume with 3 trades. The average volume for the last 60 days is 222,752 and the stock's 52-week low/high is $0.05/$0.20.

MediSwipe, Inc. (MWIP)

StockHideout reported recently on MediSwipe, Inc. (MWIP), WiseAlerts, PennyTrader Publisher, PennyStockRumors.net reported earlier, and we highlight the Company, here at the QualityStocks Daily Newsletter.

Trading on the OTCQB, MediSwipe, Inc. is a merchant payment solutions and financial products enterprise for the medical health care industry. They offer a complete portfolio of secure and reliable transaction processing and security solutions for the medical and healthcare industries, using traditional, Internet Point-of-Sale (POS), e-commerce and mobile (wireless) payment solutions. MediSwipe is based in West Palm Beach, Florida.

MediSwipe also offers digitized personal health records in conjunction with Industry Alliance Partners. The Company offers reliable merchant payment solutions and closed loop pre-paid stored value and loyalty cards as a unique cash alternative to these regulated and e-commerce businesses specializing within the healthcare sector.

MediSwipe provides online and wireless merchant payment solutions globally. Their alliances provide an electronic payment processing suite of services enabling merchants to accept various credit and debit cards, as well as ATM cards and ACH check drafts for payment of a retail, service, mail-order, or Internet merchant. MediSwipe offers services, including merchant account activation, gateway connections, Web development, and social network engines.

Their solutions provide merchants with their own merchant account, online processing of credit cards (Visa, MasterCard, American Express, and Discover), shopping cart links, virtual terminal, and site enablement. MediSwipe is not limited to one provider. Moreover, the Company has exclusive banking relationships for medical marijuana clients who understand this business and the regulation challenges the Company faces. MediSwipe can shop for the best rate in healthcare credit card processing services to fit their clients' needs.

MediSwipe has acquired certain assets of SweetMD, Inc. This enterprise is a unique telemedicine and online healthcare platform portal based in Las Vegas, Nevada. SweetMD has developed a program to bring affordable healthcare services to individuals, families and small businesses.

Yesterday, MediSwipe announced that their Board of Directors authorized the Company to file the S-1 registration statement of their 800 Commerce, Inc. for the benefit of their shareholders. MediSwipe received the final legal opinion necessary and submitted the full document for filing this week. 800 Commerce (www.800Commerce.com) provides white label mobile and payment solutions for business designed to drive return on investment for high-volume clients and/or customized branded advertisers.

The view is that 800 Commerce will become an independent and fully reporting company listed on the Over-the-Counter Bulletin Board (OTCBB). As part of the overall plan, the common stock of 800 Commerce will be distributed to MediSwipe shareholders upon obtaining an effective registration with the Securities and Exchange Commission (SEC) and upon obtaining an OTCBB listing. The record date for shareholders of MediSwipe shall be determined at some time in the near future as the Company continues through the registration process.

MediSwipe, Inc. (MWIP), closed Tuesday’s session at $0.0034, down 2.86%, on 4,467,561 volume with 59 trades. The average volume for the last 60 days is 262,812 and the stock's 52-week low/high is $0.001/$0.007.

graphic

The QualityStocks
Company Corner

graphic
graphic

VistaGen Therapeutics, Inc. (VSTA)

The QualityStocks Daily Newsletter would like to spotlight VistaGen Therapeutics, Inc. (VSTA). Today, VistaGen Therapeutics, Inc. closed trading at $0.75, even with yesterday's close, on 19,350 volume with 10 trades. The stock’s average daily volume over the past 60 days is 188, and its 52-week low/high is $0.06/$3.15.

VistaGen Therapeutics, Inc. today reported completion of the previously announced $3.25 million financing commitment with Platinum Long Term Growth VII, LLC (Platinum) and approximately $3.0 million strategic debt restructuring, bringing the company's three largest institutional shareholders and its patent counsel together in a tremendous vote of confidence for VistaGen's strategic plan to achieve multiple in-lab and in-clinic, transformative milestones in the coming year. CEO of VistaGen, Shawn K. Singh, called it the perfect opportunity to fully realize the vast commercial potential of the company's stem cell technology platform and AV-101 clinical program, with the advantages of VistaGen's stem cell-based bioassay systems for improving the predictability of drug development cycles and lowering the cost of new drug R&D, being noted in particular.

VistaGen Therapeutics, Inc. (VSTA) is a biotechnology company applying stem cell technology for drug rescue and cell therapy. Drug rescue combines human stem cell technology with modern medicinal chemistry to generate new chemical variants ("drug rescue variants") of once-promising drug candidates that have been discontinued during late-stage preclinical development due to heart or liver safety concerns. VistaGen also focuses on cell therapy, or regenerative medicine, which includes repairing, replacing or restoring damaged tissues or organs.

VistaGen's versatile stem cell technology platform, Human Clinical Trials in a Test Tube™, has been developed to provide clinically relevant predictions of potential heart and liver toxicity of promising new drug candidates long before they are ever tested on humans.

By more closely approximating human biology than conventional animal studies and other nonclinical techniques and technologies currently used in drug development, VistaGen's human stem cell-based bioassay systems can improve the predictability of the drug development cycle and lower the cost of new drug research and development by identifying product failures earlier in the cost curve. According to the Food and Drug Administration even only a ten percent improvement in predicting failure before clinical trials could save $100 million in development costs, which savings ultimately could be passed on to patients.

Using mature human heart cells produced from stem cells, VistaGen has developed and internally validated CardioSafe 3D™, a novel three-dimensional (3D) bioassay system for predicting the in vivo cardiac effects of new drug candidates before they are tested in humans. VistaGen is now focused on using CardioSafe 3D™ to generate up to two new, safer small molecule drug rescue variants every twelve to eighteen months. VistaGen anticipates that these drug rescue variants will be modified versions of once-promising new drug candidates that have been discontinued by pharmaceutical companies and academic research institutions because of heart toxicity concerns, despite substantial prior investment and positive efficacy data demonstrating their potential therapeutic and commercial benefits. In most cases, VistaGen plans to license or sell its new, safer drug rescue variants in strategic partnering arrangements with global pharmaceutical companies, arrangements providing VistaGen with both near term and downstream milestone payments and economic participation rights but without future development cost obligations.

VistaGen's lead drug candidate, AV-101, is in Phase Ib development in the U.S. for treatment of neuropathic pain, a serious and chronic condition causing pain after an injury or disease of the peripheral or central nervous system.

Neuropathic pain affects approximately 1.8 million people in the U.S. alone. Although the current active AV-101 IND is for the treatment of neuropathic pain, VistaGen's development plan and regulatory strategy for AV-101 has been designed to allow its Phase 1 safety studies to support Phase 2 development for depression, epilepsy, Huntington's Disease and Parkinson's disease, indications for which there is now supporting preclinical efficacy data. To date, VistaGen has been awarded over $8.5 million from the U.S. National Institutes of Health (NIH) for development of AV-101.

VistaGen is also developing LiverSafe 3D™, a novel predictive liver toxicity and drug metabolism bioassay system for drug rescue applications. In parallel with drug rescue activities, the Company is funding early-stage nonclinical studies focused on potential cell therapy applications of its Human Clinical Trials in a Test Tube™ platform. Disclaimer

VistaGen Therapeutics, Inc. Company Blog

VistaGen Therapeutics, Inc. News:

VistaGen Therapeutics Completes $3.25 Million Financing and $3.0 Million Debt Restructuring

VistaGen Therapeutics Announces Strategic Financing With Platinum Long Term Growth Fund

VistaGen CEO Issues Update Letter to Stockholders

Teletouch Communications, Inc. (TLLE)

The QualityStocks Daily Newsletter would like to spotlight Teletouch Communications, Inc. (TLLE). Today, Teletouch Communications, Inc. closed trading at $0.4610, off by 7.80%, on 17,937 volume with 10 trades. The stock’s average daily volume over the past 60 days is 25,514, and its 52-week low/high is $0.253/$0.89.

Teletouch Communications, Inc. reported audited consolidated results via a 10-Q filing and announced Q1 2012 financial results recently (period ended Aug 31), bringing another successful quarter to the company's over 48-year track record of success in the wireless telecom space, with total revenues of $5.22 million and $0.38 million in income from continuing operations. Also noted were key operational highlights for the quarter, including the National Distribution Agreement in June with TCT Mobile to sell Alcatel OneTouch® branded cellular handsets, retention of Timmy Monico as new distribution division VP and worldwide wholesale sales leader, the $1.5 million divestment of the company's legacy Two-Way Radio/Public Safety Equipment, and a negotiated term sheet with a new lender to resolve the senior revolving and term credit facilities.

Teletouch Communications, Inc. (TLLE) offers a comprehensive suite of wireless telecommunications solutions, including cellular, GPS-telemetry, and wireless messaging. Founded in 1964, the company provides its products and services to consumers, businesses, and government agencies, operating a chain of 11 retail and authorized agent stores, in conjunction with its direct sales force, call center operations, and various retail eCommerce websites.

Through its wholly owned subsidiary, Progressive Concepts, Teletouch operates a national distribution business, PCI Wholesale, primarily serving Tier-1 (AT&T, T-Mobile, Verizon, Sprint) cellular carrier agents, Tier-2, Tier-3, and rural carriers, as well as auto dealers and smaller consumer electronics retailers. The subsidiary's international sales coverage includes Canada, Mexico, Brazil, Singapore, and China.

The company is currently focusing on growing its core wholesale distribution business. The business plan being executed includes selling non-core corporate assets and reviewing potential acquisition opportunities. Operators and retailers of all sizes are seeking new sources of revenue at lower costs, creating a large opportunity to provide great products and value-added distribution capabilities at competitive prices.

Teletouch's management team has extensive experience in financing, acquiring, and operating retail, wireless and other related companies. Robert McMurrey, Chairman and CEO, guided Teletouch's original external expansion with the completion of over 15 acquisitions to date. Today, the company supports over 60,000 wireless customers, leveraging its long-standing relationships and global presence to drive future earnings growth. Disclaimer

Teletouch Communications, Inc. Blog

Teletouch Communications, Inc. News:

Teletouch Reports First Quarter 2013 Fiscal Year Results

Teletouch Returns as Official Cellular Sponsor for the 10th Anniversary ESPN 2012 Bell Helicopter Armed Forces Bowl

Teletouch Announces Distribution Agreement with Unimax Communications for Sales of UMX Branded Cellular Handsets in North America

TNI BioTech, Inc. (TNIB)

The QualityStocks Daily Newsletter would like to spotlight TNI BioTech, Inc. (TNIB). Today, TNI BioTech, Inc. closed trading at $2.92, up 2.46%, on 33,098 volume with 41 trades. The stock’s average daily volume over the past 60 days is 38,023, and its 52-week low/high is $0.72/$10.01.

TNI BioTech, Inc. (TNIB) is focused on utilizing patented immunotherapy to activate and mobilize the body's immune system to combat fatal diseases. The company's products and technologies improve the treatment and diagnosis of cancer, infections such as HIV/AIDS, and autoimmune diseases. Future initiatives include treatment for multiple sclerosis, herpes viral infections, and other conditions that result in altered-immune response.

The company's product portfolio currently includes IRT-101, an active immunotherapy that works by activating a patient's immune system against infectious diseases and tumor cells; IRT-102, an adaptive immunotherapy that works by isolating and enriching a patient's own immune cells; and IRT-103, an active immunotherapy that works by activating a patient's immune system against HIV/AIDS and tumor cells.

Leveraging the advantages of today's cutting-edge treatment options, the company aims to meet the growing demand for quality healthcare with safer, more effective radiation therapy; new-targeted drug therapies; and minimally invasive surgical alternatives around the world. TNI BioTech most recently signed a letter of intent to open clinics in Africa that will provide advanced treatment for cancer, HIV/AIDS, and autoimmune diseases.

The company plans to continue clinical trials in China during 2012 and 2013, and anticipates starting trials in the United States by early 2013.The company is also in negotiations to acquire a number of other immunotherapy products, patents, and therapies. Led by a management team with decades of experience and solid business plan, TNI BioTech is poised to improve healthcare with active and adaptive forms of improved immunotherapies. Disclaimer

TNI BioTech, Inc. Company Blog

TNI BioTech, Inc. News:

Dr. Henry "Skip" Lenz, Pharm.D, Joins TNI BioTech, Inc., as Quality Control Officer

TNI BioTech Signs Agreement With Government of Malawi to Open an Oncology & Infectious Disease Clinic at Queen Elizabeth Central Hospital

TNI BioTech, Inc. Signs Memorandum of Agreement to Open Pharmaceutical Plant for the Production of IRT-103 (LDN)

GreeneStone Healthcare Corp. (GRST)

The QualityStocks Daily Newsletter would like to spotlight GreeneStone Healthcare Corp. (GRST). Today, GreeneStone Healthcare Corp. closed trading at $1.80, up 0.56%, on 132,065 volume with 60 trades. The stock’s average daily volume over the past 60 days is 9,339, and its 52-week low/high is $0.70/$1.83.

GreeneStone Healthcare Corp. (GRST) is focused on operating medical and healthcare clinics in Ontario, Canada, offering addiction treatment, colonoscopy, endoscopy, minor cosmetic procedures, and executive health assessment programs. The company adds overflow capacity to an increasingly stretched provincial healthcare system, and provides private alternatives to publicly underserviced healthcare needs.

Ontario's public healthcare cost has grown at a compounded 7.1% rate over the past 10 years, now accounting for approximately $77B in government spending compared to $39B in 2000. This cost explosion is similar for the country as a whole, growing at 7.4% over the same period. The need for practical change to the system is immediate as demand continues to rise.

Governments are increasingly looking to private alternatives to address the growing trade-off between costs vs. service in the public healthcare system. Private services are expanding beyond their traditional place as overflow capacity to relieve wait times. GreeneStone Healthcare is particularly well positioned with a first-mover advantage in mental healthcare – a highly underserviced niche.

The company currently offers its various medical services via three medical clinics. Future plans include establishing partnerships for accelerated growth as well as dual-listing on CNSX. With positive revenue growth and cash flow positive status recently achieved, GreeneStone is methodically extending its vertical expertise in the healthcare industry. Disclaimer

GreeneStone Healthcare Corp. Company Blog

GreeneStone Healthcare Corp. News:

GreeneStone Implementing 'Build & Buy' Growth Strategy To Capitalize On Huge Opportunity In Behavioral Treatment

GreeneStone Supports the Cause of Mental Health with Charitable Foundation

GreeneStone Muskoka Once Again Featured on Intervention Canada

VistaGen Therapeutics, Inc. (VSTA) Secures $3.25 Million Financing and Completes $3.0 Million Debt Restructuring

VistaGen Therapeutics, a biotechnology company applying human pluripotent stem cell technology for drug rescue and novel pharmaceutical assays, just announced the completion of the previously announced $3.25 million financing commitment with Platinum Long Term Growth VII, LLC (Platinum) and approximately $3.0 million strategic debt restructuring. The combined transactions involve the company’s three largest institutional shareholders and its patent counsel.

“Today marks a significant turning point for VistaGen. These transactions represent a tremendous vote of confidence by four of our major stakeholders and position us to realize the full measure of our commercial opportunities involving our stem cell technology platform and AV-101 clinical program,” stated Shawn K. Singh, VistaGen’s Chief Executive Officer.

“Our expectations are set very high. Over the next 12 months, we plan to achieve multiple transformative milestones, both in the lab and in the clinic. This funding provided by Platinum, combined with our strategic equity-based restructuring transactions with Cato Research, Morrison & Foerster and University Health Network, will be instrumental in our success,” concluded Mr. Singh.

Allen Cato, M.D., Ph.D., co-founder and Chief Executive Officer of Cato Research, commented, “By more closely approximating human biology, VistaGen’s stem cell-based bioassay systems can improve the predictability of the drug development cycle and lower the cost of new drug research and development. We are pleased to support VistaGen’s efforts to transform the drug development process and to bring safer, more effective therapies to market.”

Michael Goldberg, M.D., Portfolio Manager of Platinum Long Term Growth VII, added, “VistaGen has been, and continues to represent, an excellent investment opportunity for Platinum. Our continued commitment toward supporting VistaGen underscores our confidence in the Company’s novel stem cell technologies and AV-101.”

Investors who wish to obtain further information regarding these transactions should view the company’s Current Reports on Form 8-K filed with the U.S. Securities and Exchange Commission (SEC).

Teletouch Communications, Inc. (TLLE) Announces First Quarter FY 2013 Results and Highlights

Yesterday after the closing bell, Teletouch Communications reported its financial results and highlights for the first quarter ended August 31, 2012.

1st Quarter Results – Financial (as reported)

• Total operating revenues of $5.22 million
• Income from continuing operations of $0.38 million
• EBITDA from continuing operations of $0.60 million
• Net loss of $0.11 million
• Reduced total liabilities by $2.36 million

1st Quarter Results – Financial (adjusted for non-cash and significant non-recurring items)

• Adjusted income from continuing operations of $0.56 million
• Adjusted EBITDA from continuing operations of $0.78 million
• Adjusted net income of $0.07 million

1st Quarter Highlights – Business

• In June 2012, signed National Distribution Agreement with TCT Mobile Multinational, Limited to sell Alcatel OneTouch® branded cellular handsets. Initial inventory expected to be available by late September to early October 2012.
• In July 2012, hired 30+ year industry veteran and former head of CellStar USA, Timmy Monico, as new distribution division VP and leader of worldwide wholesale sales.
• Sold legacy Two-Way Radio/Public Safety Equipment business to DFW Communications, Inc. for approximately $1.5 million in August 2012.
• Negotiated term sheet with prospective new lender for senior revolving and term credit facilities to replace current credit facility with Thermo Credit LLC. The due diligence process started in late August 2012, with closing targeted for end of October 2012.

“As we prepare for our initial handset deliveries and the related sales growth in our wholesale distribution division, we are making solid progress in the basic blocking and tackling of running the overall business,” commented T. A. “Kip” Hyde, Jr., President, Chief Operating Officer and Director of Teletouch. “With the sale of the two-way radio and public safety equipment division, we continue to pay down debt and reduce our total liabilities. Through segment cost reductions and AT&T subscriber transfer fees, our operating income from continuing operations increased over half-a-million dollars from the same period last year to approximately $375,000 for this year’s quarter. Similarly, our net loss from continuing operations was reduced by over $600,000 from the prior fiscal year’s first quarter results. After guidance from the State, we filed a petition for redetermination and hearing, in order to facilitate and complete the process of creating a formal compromise and payment arrangement for the sales tax assessment with the State of Texas. When adjusted for non-cash stock compensation expense and other items, we generated net income of $73,000 for the quarter.”

Hyde added, “We are now substantially through due diligence with a new lender to replace Thermo Credit, with closing currently targeted for October 2012 month-end. Once closed, this new senior facility is designed to facilitate growth in our wholesale distribution segment, as well as support our ongoing cellular services segment. When combined with our latest distribution agreement with Unimax Communications for the import and sales of UMX® branded low cost CDMA handsets, we feel we are well positioned for strong performance through the back half of this fiscal year.”

A conference call has been scheduled to review the fiscal first quarter 2013 earnings on October 24, 2012, at 4:15 p.m. Eastern (3:15 p.m. Central). Investors interested in joining the call should dial 866-901-2585 or 404-835-7099. Callers will be asked to provide their first and last names, email address, and company and/or financial institution name, as applicable. Participants are advised to dial in approximately 10-15 minutes before the conference call is scheduled to begin. Management will be taking questions after their prepared remarks. The moderator will explain to participants how to queue up their questions.

To learn more about Teletouch, visit www.teletouch.com

International Stem Cell Corp. (ISCO) and the Push to Eradicate Parkinson’s Disease

Of the many diseases now undergoing research for the possible use of stem cell treatment, diseases associated with neurological damage represent some of the most exciting possibilities. Neurological diseases have been among the most intransigent, refusing to yield the answers needed to gain a complete understanding or provide comprehensive treatments.

Parkinson’s disease is a good example. For reasons not yet clear, a critical part of the brain can, with age, lose cells that produce dopamine, an important neurotransmitter. Deficiencies or excesses of dopamine have been implicated in a number of neurological diseases, including schizophrenia and attention deficit hyperactivity disorder (ADHD). In the case of Parkinson’s, the result is difficulty with simple motor movements, making it hard to walk or to do fine movements. Later it can become difficult to even stand or talk, and can lead to various forms of dementia. Although some occurrences of Parkinson’s are known to be associated with genetic factors, the underlying causes of most cases are still unknown. Although various drugs have been used to help overcome Parkinson’s symptoms, with so much yet to be learned about the disease itself there seemed little hope for a cure.

Much of that has changed now with the development of stem cell technology. Recent research suggests that stem cells can be used to repair various types of neurological damage, actually generating new nerve cells that can be introduced to damaged areas. Diseases like Parkinson’s and ALS (Lou Gehrig’s disease) are now being targeted as front-line candidates for stem cell research, and important progress is being made.

International Stem Cell Corp., developers of a stem cell technology based upon parthenogenesis, the creation of pluripotent human stem cells from unfertilized oocytes (eggs), is primarily focused on three therapeutic markets, one of which is Parkinson’s disease. Parthenogenetic stem cells are of special value because they have a number of advantages over other stem cell sources. They do not come from human embryos, so there is no controversy about embryo destruction. They are pluripotent, able to differentiate into many different types of cell. And finally, because of the way they are produced, parthenogenetic stem cells are far less likely to face immune rejection by the patient.

For additional information, visit www.InternationalStemCell.com

All Grade Mining, Inc. (HYII) Continues Ore Extraction Efforts in the Republic of Chile

All Grade Mining, a development-stage mining company specializing in the acquisition of mining concessions in all phases, sizes, and minerals, continues its iron ore extraction efforts in South America, chiefly taking place at the present time in the Republic of Chile. During the third quarter 2012, the company has been focused on the commencement of mining operations for iron ore on its Salitrosa property, located in the Atacama Region of Chile.

Located 28 kilometers from Chañaral and 60 kilometers from the Caldera port, the Salitrosa Iron Ore Mine consists of 741 hectares spanning 24 square kilometers. The property has an estimated iron ore reserve of more than 40 million metric tons, based on magnometric and geologic studies conducted on the property. All Grade expects to bring monthly production at the Salitrosa Mine up to 150,000 metric tons by mid-2013. The company additionally expects to see substantial cash flow from these operations in the near future, which will enable further expansion of All Grade’s operations in Chile.

All Grade recently acquired the Jose Del Transito Project, located approximately 3 kilometers north-southeast of Ovalle. This mine, ideal for both open pit and stope mining, is a copper oxide project with very good grades, ranging from 1.8 to 2.4 percent. The Jose Del Transito Project is currently producing up to 1,100 tons of copper per month, and the company is in the process of submitting permits with the Chilean government to double that production later this year. The production lifespan of this project is estimated to be potentially 15 years.

Led by an experienced team of executives and mining professionals, All Grade Mining is a development-stage company currently focused on the extraction of iron ore and copper ore from mines located in the Republic of Chile. The company’s mission is to acquire mining concessions in all phases, sizes, and minerals.

For more information, visit www.AllGradeMining.com

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

OTCPicks
(HRDN)

2.

Bull in Advantage
(HEMP)

3.

smartOTC
(DSTI)

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















The QualityStocks By The Numbers Report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251